Abstract
Following the discovery of the hepatitis D virus (HDV) in the late 1970s and the development of assays to diagnose its infection, epidemiologic studies indicated that hepatitis D was endemic worldwide, with its prevalence varying in different countries. In most patients, chronic hepatitis D ran a severe and progressive course; the clinical profile of the disease was characterized by the presence of hepatitis B surface antigen (HBsAg) in blood, elevated alanine transaminase (ALT), an aggressive hepatitis on histology, and markers of HDV replication with absent markers of HBV replication in serum. With reduction of adult-acquired HBV infection in the past 20 years, the prevalence of HDV has also declined significantly in Europe and the industrialized world, because of reduction in the number of HBsAg-carriers necessary to HDV to persist. This has led to the less frequent diagnosis of hepatitis D. However, HDV infection has not disappeared. Europe still has a reservoir of the virus, sustained by two different pools of HDV-infected patients: the residual aging domestic pool that survived the brunt of the hepatitis D epidemic in the 1970s and 1980s, and the population of young patients with recent HDV infections migrating to Europe from areas where HDV remains endemic. The predominant clinical pattern is advanced cirrhosis in most domestic patients with long-standing disease, and a florid disease resembling the prototype pattern of HDV disease described in the 1980s, in the emigrants.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Taylor JM: Structure and replication of hepatitis delta virus RNA. Curr Top Microbiol Immunol 2006, 307:1–23.
Kuo MY, Chao M, Taylor J: Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol 1989, 63:1945–1950.
Chang J, Sigal LJ, Lerro A, Taylor J: Replication of the human hepatitis delta virus genome is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences. J Virol 2001, 75: 3469–3473.
Chang J, Nie X, Chang HE, et al.: Transcription of hepatitis delta virus RNA by RNA polymerase II. J Virol 2008, 82: 1118–1127.
Been MD: HDV ribozymes. Curr Top Microbiol Immunol 2006, 307:47–65.
Huang WH, Chen CW, Wu HL, Chen PJ: Post-translational modification of delta antigen of hepatitis D virus. Curr Top Microbiol Immunol 2006, 307:91–112.
Shih HH, Jeng KS, Syu WJ, et al.: Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis d virus. J Virol 2008, 82:2250–2264.
Manesis EK, Schina M, Le Gal F, et al.: Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring. Antivir Ther 2007, 12:381–388.
Rizzetto M, Ponzetto A, Forzani I: Hepatitis delta virus as a global health problem. Vaccine 1990, 8(Suppl):S10–S4.
Smedile A, Rizzetto M, Gerin JL: Advances in hepatitis D virus biology and disease. Prog Liver Dis 1994, 12:157–175.
Rizzetto M, Verme G, Recchia S, et al.: Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 1983, 98:437–441.
Hadziyannis SJ, Hatzakis A, Papaioannou C, et al.: Endemic hepatitis delta virus infection in a Greek community. Prog Clin Biol Res 1987, 234:181–202.
Fattovich G, Giustina G, Christensen E, et al.: Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 2000, 46:420–426.
• Rizzetto M: Hepatitis D: thirty years after. J Hepatol 2009, 50:1043–1050. This article provides a comprehensive review dealing with the virologic and clinical features of HDV infection.
Smedile A, Lavarini C, Farci P, et al.: Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. Am J Epidemiol 1983, 117:223–229.
Sagnelli E, Stroffolini T, Ascione A, et al.: The epidemiology of hepatitis delta infection in Italy. Promoting Group. J Hepatol 1992, 15: 211–215.
Sagnelli E, Stroffolini T, Ascione A, et al.: Decrease in HDV endemicity in Italy. J Hepatol 1997, 26: 20–24.
Gaeta GB, Stroffolini T, Chiaramonte M, et al.: Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology 2000, 32:824–827.
Navascués CA, Rodríguez M, Sotorrío NG, et al.: Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol 1995, 90:1981–1984.
Huo TI, Wu JC, Lin RY, et al.: Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol 1997, 12:747–751.
Değertekin H, Yalçin K, Yakut M: The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies. Turk J Gastroenterol 2006, 17:25–34.
• Cross TSJ, Rizzi P, Horner M, et al.: The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol 2008, 80: 277–282. This study showed that in England the current modalities of investigating carriers of the HBsAg often ignore HDV testing. It reports the current prevalence of HDV infection in the country.
Stroffolini T, et al.: Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study. J Med Virol 2009, 81:1999–2006.
• Wedemeyer H, Heidrich B, Manns MP: Hepatitis D virus infection—not a vanishing disease in Europe! Hepatology 2007, 45:1331–1332. This study showed that there is a residual presence of hepatitis D infection in Germany.
• Le Gal F, Castelneau C, Gault E, et al.: Hepatitis D virus infection. Not a vanishing disease in Europe! Hepatology 2007, 45:1332–1333. This study showed that there is a residual presence of hepatitis D infection in France.
Disclosure
No potential conflict of interest relevant to this article was reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rizzetto, M. Delta Hepatitis: Forgotten, but Not Gone. Curr Hepatitis Rep 9, 239–242 (2010). https://doi.org/10.1007/s11901-010-0058-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11901-010-0058-y